Cancer: Three 'warning' sensations that appear on the toilet - 'Crucial' to identify
An expert has shared three symptoms of prostate cancer that crop up when you pee. (Source: Daily Express - Health)
Source: Daily Express - Health - September 28, 2022 Category: Consumer Health News Source Type: news

Blue Earth wins FDA nod for PSMA PET tracer NDA
The U.S. Food and Drug Administration (FDA) has accepted a new drug applicatio...Read more on AuntMinnie.comRelated Reading: Blue Earth touts positive prostate cancer trial results FDA clears clinical trial for Blue Earth radiopharmaceutical Bracco forms unit to develop therapeutic radiopharmaceuticals Blue Earth highlights new Axumin research Blue Earth points to Axumin studies at ASCO meeting (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 28, 2022 Category: Radiology Source Type: news

Blue Earth Diagnostics wins FDA acceptance for NDA
The U.S. Food and Drug Administration (FDA) has accepted a new drug applicatio...Read more on AuntMinnie.comRelated Reading: Blue Earth touts positive prostate cancer trial results FDA clears clinical trial for Blue Earth radiopharmaceutical Bracco forms unit to develop therapeutic radiopharmaceuticals Blue Earth highlights new Axumin research Blue Earth points to Axumin studies at ASCO meeting (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 27, 2022 Category: Radiology Source Type: news

Statins: The cholesterol-lowering medication could treat prostate cancer - new study
Apart from busting your cholesterol levels, statins could also act as a treatment for prostate cancer, new research suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - September 27, 2022 Category: Consumer Health News Source Type: news

Enzalutamide Improves Survival in Metastatic Prostate Cancer Enzalutamide Improves Survival in Metastatic Prostate Cancer
A primary analysis of the ARCHES trial finds that the addition of enzalutamide to androgen deprivation therapy may help prolong the survival of metastatic hormone-sensitive prostate cancer patients.Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2022 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Statins 'could treat prostate cancer': Drugs starve stubborn tumours, trial finds
Researchers in Glasgow found protein prostate-specific antigen (PSA) levels - a protein produced by the organ - dropped substantially in all 12 patients treated with statins. (Source: the Mail online | Health)
Source: the Mail online | Health - September 26, 2022 Category: Consumer Health News Source Type: news

Armored CAR T Cells Break Through Immune Suppression in Solid Tumors
Researchers determined the safety and antitumor ability of genetically engineered CAR T cells that circumvent immune suppression in a prostate cancer phase I clinical trial. (Source: The Scientist)
Source: The Scientist - September 26, 2022 Category: Science Tags: Sponsored Article Source Type: news

How Genes Affect Healthy Life Years; Active Surveillance for Prostate Cancer
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 24, 2022 Category: Psychiatry Source Type: news

Two Factors to ID Men at Highest Risk for Prostate Cancer Death Two Factors to ID Men at Highest Risk for Prostate Cancer Death
Prostate cancer risk stratification based on family history plus inherited polygenic risk can better identify men at highest risk of dying from prostate cancer at an early age, new data suggest.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Coffee Intake Linked to Longer Prostate Cancer - Specific Survival
Longer prostate cancer - specific survival seen for specific subgroups, including those with the CYP1A2 AA genotype (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 23, 2022 Category: Cancer & Oncology Tags: Oncology, Urology, Journal, Source Type: news

Coffee Intake Linked to Longer Prostate Cancer-Specific Survival
THURSDAY, Sept. 22, 2022 -- High coffee intake is associated with longer prostate cancer-specific survival (PCSS) for certain subgroups of men, including those with the CYP1A2 AA genotype, according to a study published online Aug. 19 in European... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2022 Category: Pharmaceuticals Source Type: news

Neoadjuvant Novel Hormonal Agents Studied in High - Risk Prostate Cancer
Neoadjuvant therapy with an NHA associated with longer time to biochemical recurrence, prolonged metastasis - free survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 22, 2022 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Surgery, Urology, Journal, Source Type: news

QTscan gets FDA nod for new metrics
QT Imaging has received clearance from the U.S. Food and Drug Administratio...Read more on AuntMinnie.comRelated Reading: QT Imaging touts breast glandular clinical study QT Imaging touts prostate cancer screening study QT Imaging touts study results for QTscan QT Imaging announces EMEA distribution agreement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 22, 2022 Category: Radiology Source Type: news

Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
THURSDAY, Sept. 22, 2022 -- Neoadjuvant therapy with a novel hormonal agent prior to radical prostatectomy is associated with better outcomes for men with high-risk prostate cancer versus upfront radical prostatectomy, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2022 Category: Pharmaceuticals Source Type: news

Mayo Clinic researchers identify drug resistance factors for advanced prostate cancer
ROCHESTER, Minn. — In a new study published in Molecular Cancer Research, Mayo Clinic researchers identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable and castration-resistant prostate cancer. Liewei Wang, M.D., Ph.D. "We defined a potential strategy for both responders and nonresponders of the drug that may help men overcome resistance and prolong survival," says Liewei Wang, M.D., Ph.D., the Bernard and Edith Waterman Director, Pharmacogenomics… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - September 22, 2022 Category: Research Source Type: news